Single-session RFA of lung and liver proves feasible
Interventional radiologists can now kill two “birds” with just one probe. Simultaneous radio-frequency ablation of hepatic and pulmonary tumors is feasible, according to Italian researchers.
Interventional radiologists can now kill two "birds" with just one probe. Simultaneous radio-frequency ablation of hepatic and pulmonary tumors is feasible, according to Italian researchers.
From July 2002 through February 2004, investigators at the University of Florence performed 65 RF ablations in 25 patients with hepatic and pulmonary metastases from colorectal carcinoma. All the procedures were carried out under CT or ultrasound guidance. The researchers found that the ablation of these tumors could be done simultaneously in a single-session procedure.
"We wanted to prove that this procedure was technically feasible and that it would not add to the patients' complications," said coauthor Dr. Davide Becanni.
RFA was performed under CT guidance in 13 cases and with ultrasound guidance in 16. Both hepatic and pulmonary lesions were treated in a single-session procedure using one RF generator with either single or cluster probes. RFA successfully ablated all lesions, as confirmed by either CT or PET follow-up. No liver complications were reported, although five patients who were treated for pulmonary metastases developed pneumothorax.
Physicians still need to define the best target population and the cost-benefit relation for dual RFA procedures. But his study shows that RFA can reduce hospitalization time without adding to the complication rate, Becanni said.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Study Shows Benefits of AI in Detecting Lung Cancer Risk in Non-Smokers
November 22nd 2023Artificial intelligence (AI) assessments of chest X-rays identified 28 percent of a 17,000 plus cohort of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
Could an Emerging AI System Lead to Earlier Autism Detection with DT-MRI?
November 21st 2023Through assessment of diffusion tensor MRI of the brain, a new AI system reportedly offers a 97 percent sensitivity rate in diagnosing autism in children between two to four years of age, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
